1. Home
  2. ARRY vs NEO Comparison

ARRY vs NEO Comparison

Compare ARRY & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Array Technologies Inc.

ARRY

Array Technologies Inc.

HOLD

Current Price

$9.23

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$10.26

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARRY
NEO
Founded
1989
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
ARRY
NEO
Price
$9.23
$10.26
Analyst Decision
Buy
Strong Buy
Analyst Count
19
8
Target Price
$10.21
$13.38
AVG Volume (30 Days)
4.9M
1.2M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
62.56
N/A
EPS
N/A
N/A
Revenue
$1,284,141,000.00
N/A
Revenue This Year
$15.72
$10.63
Revenue Next Year
$8.08
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
40.22
N/A
52 Week Low
$5.39
$4.72
52 Week High
$12.23
$13.74

Technical Indicators

Market Signals
Indicator
ARRY
NEO
Relative Strength Index (RSI) 60.66 68.42
Support Level $7.69 $9.35
Resistance Level $9.65 $10.66
Average True Range (ATR) 0.58 0.46
MACD 0.05 0.18
Stochastic Oscillator 83.97 84.85

Price Performance

Historical Comparison
ARRY
NEO

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that moves solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil, and the rest of the world, with the United States deriving the majority of the revenue.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: